QA: Neurotrope Inc in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001513856_2020_Neurotrope_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001513856, Neurotrope Inc

  xvar xval
0 AssetsCurrent 17,876,150
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 21,671
3 remainder_Assets 0
4 LiabilitiesCurrent 479,056
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,185,412
9 ResearchAndDevelopmentExpense 4,537,110
10 remainder_Expenses 3,807,880
11 remainder_Revenues 0
12 remainder_NetIncome 1,633,652
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 17,897,821
1 Liabilities 479,056
2 Expenses 14,530,402
3 Revenues 0
4 StockholdersEquity 17,418,765
5 NetIncome -12,896,750
6 ComprehensiveNetIncome -12,896,750
7 BaseVar 17,270,466
8 EconomicCapitalRatiobeforeLimitedLiability 2.73
9 EconomicCapitalRatio 3.51

Edgar->Model Mapping

Feature Distribution

Change over Time